TAVT-18 (sirolimus)

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
158	結節性硬化症	1

158. 結節性硬化症

臨床試験数 : 112 / 薬物数 : 71 - (DrugBank : 19) / 標的遺伝子数 : 35 - 標的パスウェイ数 : 118

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04595513 (ClinicalTrials.gov)	September 8, 2020	6/10/2020	Stopping TSC Onset and Progression 2: Epilepsy Prevention in TSC Infants	Stopping TSC Onset and Progression 2: Epilepsy Prevention in TSC Infants	Tuberous Sclerosis Complex;Epilepsy	Drug: TAVT-18 (sirolimus)	Children's Hospital Medical Center, Cincinnati	NULL	Active, not recruiting	N/A	6 Months	All	5	Phase 1/Phase 2	United States

First Previous1Next Last